J Am Chem Soc. 2018 Jun 13;140(23):7282-7291. doi: 10.1021/jacs.8b03584. Epub 2018 May 29.
The intracellular delivery of biofunctional enzymes or therapeutic proteins through systemic administration is of great importance in therapeutic intervention of various diseases. However, current strategies face substantial challenges owing to various biological barriers, including susceptibility to protein degradation and denaturation, poor cellular uptake, and low transduction efficiency into the cytosol. Here, we developed a biomimetic nanoparticle platform for systemic and intracellular delivery of proteins. Through a biocompatible strategy, guest proteins are caged in the matrix of metal-organic frameworks (MOFs) with high efficiency (up to ∼94%) and high loading content up to ∼50 times those achieved by surface conjunction, and the nanoparticles were further decorated with the extracellular vesicle (EV) membrane with an efficiency as high as ∼97%. In vitro and in vivo study manifests that the EV-like nanoparticles can not only protect proteins against protease digestion and evade the immune system clearance but also selectively target homotypic tumor sites and promote tumor cell uptake and autonomous release of the guest protein after internalization. Assisted by biomimetic nanoparticles, intracellular delivery of the bioactive therapeutic protein gelonin significantly inhibits the tumor growth in vivo and increased 14-fold the therapeutic efficacy. Together, our work not only proposes a new concept to construct a biomimetic nanoplatform but also provides a new solution for systemic and intracellular delivery of protein.
通过系统给药将生物功能酶或治疗性蛋白质递送到细胞内,对于各种疾病的治疗干预非常重要。然而,由于存在各种生物学屏障,包括对蛋白质降解和变性的敏感性、较差的细胞摄取能力以及向细胞质内的低转导效率,当前的策略面临着巨大的挑战。在这里,我们开发了一种用于蛋白质系统内和细胞内递送的仿生纳米颗粒平台。通过一种生物相容性策略,客蛋白被高效地(高达约 94%)装入金属有机骨架(MOF)的基质中,并且负载量高达约 50 倍,是通过表面结合所达到的负载量的 50 倍,并且纳米颗粒进一步用外泌体(EV)膜进行了修饰,修饰效率高达约 97%。体外和体内研究表明,类 EV 纳米颗粒不仅可以保护蛋白质免受蛋白酶的消化和逃避免疫系统的清除,还可以选择性地靶向同种肿瘤部位,并在内化后促进肿瘤细胞摄取和客蛋白的自主释放。在仿生纳米颗粒的辅助下,生物活性治疗性蛋白蓖麻毒素的细胞内递送达显著抑制了体内肿瘤的生长,并使治疗效果提高了 14 倍。总之,我们的工作不仅提出了构建仿生纳米平台的新概念,而且为蛋白质的系统内和细胞内递送提供了新的解决方案。